Comparison Between Covered and Bare Cheatham-Platinum Stents for Endovascular Treatment of Patients With Native Post-Ductal Aortic Coarctation

Sohrabi, Bahram; Jamshidi, Peiman; Yaghoubi, Alireza; Habibzadeh, Afshin; Hashemi-aghdam, Yashar; Moin, Araz; Kazemi, Babak; Ghaffari, Samad; Baghayi, Mohammad Reza Abdolahzadeh; Mahmoody, Khalil

doi:10.1016/j.jcin.2013.11.018

Cited by 84 publications

(59 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…During the 31 months of follow -up, there was no difference in the rate of reCoA and pseudoaneurysm formation between patients who underwent implantation with BMS vs CS. 34 There is still no evidence indicating which stent is better in the treatment of CoA. In our opinion, CS could be the preferred treatment in adequately selected patients (eg, with severe arch obstruction, tortuosity of the aorta, aneurysms, or hypoplasia of aortic stenosis).…”

mentioning

confidence: 84%

See 1 more Smart Citation

Immediate and long term outcomes of native aortic coarctation and postsurgical aortic recoarctation treated with stent implantation: one Center experience

Sulik¹,

Fiszer²,

Scalone³

et al. 2017

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

INTRODUCTION Stent implantation has become the treatment of choice for native aortic coarctation (CoA) and postsurgical aortic recoarctation (reCoA) in adults and adolescents.OBJECTIVES This study aimed to compare the immediate and long -term outcomes of patients with native CoA and postsurgical reCoA who underwent stent implantation in our center. PATIENTS AND METHODSThe data of 136 patients with native CoA and reCoA who underwent stent implantation between May 1999 and December 2016 were retrospectively analyzed. The study population was divided into 2 groups: 108 patients with native CoA and 28 patients with reCoA. Clinical and procedural characteristics and immediate and long -term outcomes after the intervention were compared between the groups. The use of antihypertensive drugs was analyzed in all patients. RESULTSThere were no significant differences in the clinical characteristics of the study groups. The gradient before the intervention was significantly higher in the native CoA than in the reCoA group (P = 0.011), and the diameter of stenosis before the intervention was smaller in the native CoA group compared with the ReCoA group (P = 0.003). Procedural treatment was successful in 77.8% of the patients with native CoA and 78.5% of those with reCoA. There were no differences in the immediate and long -term outcomes between the groups. The antihypertensive treatment was tapered or discontinued in about 34% of the study population.CONCLUSIONS Stenting is an effective and safe procedure in patients with native CoA and reCoA, with good late outcomes.

show abstract

mentioning

confidence: 84%

“…Immediate follow -up Immediate complications are summarized in [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44], P = 0.011). However, the gradient after intervention was the same in both groups.…”

Section: Patients and Methods Study Population Frommentioning

confidence: 99%

Immediate and long term outcomes of native aortic coarctation and postsurgical aortic recoarctation treated with stent implantation: one Center experience

Sulik¹,

Fiszer²,

Scalone³

et al. 2017

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

show abstract

“…Both groups had no acute procedural complications, and at an average followup of 31.1 mo, the bare CP stent group had a statistically nonsignificant increase in the rate of recoarctation (6.7% vs 0%) and a nonsignificant lower incidence of pseudoaneurysm (0% vs 3.3%), compared to the covered CP stent cohort. The two cases of pseudoaneurysm in the covered stent group occurred at the proximal end of the stent, and both were successfully treated with a second covered stent with no further complications [75] . Further investigation into the safety and efficacy of covered stents is ongoing with the COAST II trial.…”

Section: Patient Follow-upmentioning

confidence: 96%

“…Hemodynamic and arch imaging outcomes superior in stent and surgical patients compared to BA group Harris et al [55] 130 3-60 mo Prospective, multicenter analysis of short and intermediate outcomes for BA in native and recurrent coarctation in children. Trend toward increased acute aortic wall injury and restenosis in native coarctation patients Sohrabi et al [75] 120…”

Section: Follow-up Outcomementioning

confidence: 99%

Coarctation of the aorta: Management from infancy to adulthood

Török

Campbell

Fleming

et al. 2015

WJC

235

151

View full text Add to dashboard Cite

Coarctation of the aorta is a relatively common form of congenital heart disease, with an estimated incidence of approximately 3 cases per 10000 births. Coarctation is a heterogeneous lesion which may present across all age ranges, with varying clinical symptoms, in isolation, or in association with other cardiac defects. The first surgical repair of aortic coarctation was described in 1944, and since that time, several other surgical techniques have been developed and modified. Additionally, transcatheter balloon angioplasty and endovascular stent placement offer less invasive approaches for the treatment of coarctation of the aorta for some patients. While overall morbidity and mortality rates are low for patients undergoing intervention for coarctation, both surgical and transcatheter interventions are not free from adverse outcomes. Therefore, patients must be followed closely over their lifetime for complications such as recoarctation, aortic aneurysm, persistent hypertension, and changes in any associated cardiac defects. Considerable effort has been expended investigating the utility and outcomes of various treatment approaches for aortic coarctation, which are heavily influenced by a patient's anatomy, size, age, and clinical course. Here we review indications for intervention, describe and compare surgical and transcatheter techniques for management of coarctation, and explore the associated outcomes in both children and adults.

show abstract

“…A recent randomized trial showed no major difference between covered and bare metal implants 16 but the numbers were small (60 in each arm) and perhaps was underpowered to detect small differences. The rate of major aortic complications is likely <5% in most series.…”

Section: Horlick and Bensonmentioning

confidence: 98%